NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in NUS news today?
Nu Skin Declares $0.06 Quarterly Dividend Payable June 10: Nu Skin’s board has declared a quarterly cash dividend of $0.06 per share, payable June 10, 2026, to shareholders of record on May 29, 2026. The distribution underscores the company’s commitment to returning capital as it operates in nearly 50 beauty and wellness markets worldwide.
Nathanson Laura sold 2.68K (~$18.01K) on May 11, 2026.
Hatchett Steven Keith bought 5.50K (~$52.85K) on Nov 11, 2025.
Nathanson Laura sold 6.49K (~$79.30K) on Sep 4, 2025.
NUS Analyst Consensus
NUS analyst coverage data. Average price target: $0.00.
Common questions about NUS
What changed in NUS news today?
Nu Skin Declares $0.06 Quarterly Dividend Payable June 10: Nu Skin’s board has declared a quarterly cash dividend of $0.06 per share, payable June 10, 2026, to shareholders of record on May 29, 2026. The distribution underscores the company’s commitment to returning capital as it operates in nearly 50 beauty and wellness markets worldwide.
Does Rallies summarize NUS news?
Yes. Rallies summarizes NUS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NUS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUS. It does not provide personalized investment advice.
